Portfolio Update

Octopus AIM VCT 2 plc

Portfolio Update

The investment portfolio of Octopus AIM VCT 2 plc (the ‘Company’) as at 13 September 2023 is as follows (the valuations being the unaudited valuations, at bid price, as at 31 July 2023):

¹ Denotes unlisted company

Since 31 July 2023 Octopus AIM VCT 2 plc has made £0.3 million investments and £0.1 million disposals.

Unless otherwise stated, all the investments set out above:

• are quoted on public markets;
• represent equity investments except in the case of Osirium which include investment through loan stock; and
• are in portfolio companies incorporated in the UK with the exception of:
  
  

Breedon Group – Jersey
Maxcyte Inc – USA
VR Education Holdings plc – Ireland
Falanx Group Limited – British Virgin Islands
Mycelx – USA
Glantus Holdings plc – Republic of Ireland
Spectral MD Holdings Ltd – USA

Current Asset Investments (unaudited)

Since 31 July 2023 there has been a disposal of £0.1 million from the current asset investments.

The capitalisation of Octopus AIM VCT 2 plc as at 31 July 2023 was as follows:

There has been no material change to the capitalisation since 31 July 2023.

For further information please contact:
Rachel Peat
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17